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Understanding Middle East respiratory syndrome 
coronavirus (MERS-CoV) transmission in dromedary 
camels is important, as they consitute a source of 
zoonotic infection to humans. To identify risk factors 
for MERS-CoV infection in camels bred in diverse con-
ditions in Burkina Faso, Ethiopia and Morocco, blood 
samples and nasal swabs were sampled in February–
March 2015. A relatively high MERS-CoV RNA rate was 
detected in Ethiopia (up to 15.7%; 95% confidence 
interval (CI): 8.2–28.0), followed by Burkina Faso (up 
to 12.2%; 95% CI: 7–20.4) and Morocco (up to 7.6%; 
95% CI: 1.9–26.1). The RNA detection rate was higher 
in camels bred for milk or meat than in camels for 
transport (p = 0.01) as well as in younger camels (p = 
0.06). High seropositivity rates (up to 100%; 95% CI: 
100–100 and 99.4%; 95% CI: 95.4–99.9) were found in 
Morocco and Ethiopia, followed by Burkina Faso (up to 
84.6%; 95% CI: 77.2–89.9). Seropositivity rates were 
higher in large/medium herds (≥51 camels) than small 
herds (p = 0.061), in camels raised for meat or milk 
than for transport (p = 0.01), and in nomadic or seden-
tary herds than in herds with a mix of these lifestyles 
(p < 0.005). 
Introduction
In September 2012, a novel coronavirus, Middle East 
respiratory syndrome coronavirus (MERS-CoV), was 
identified from a patient with a fatal viral pneumo-
nia in Saudi Arabia. This coronavirus is genetically 
related, but not identical, to the severe acute respira-
tory syndrome (SARS) coronavirus which emerged in 
southern China in 2002 [1]. As of 21 March 2017, 1,917 
human cases have been reported to the World Health 
Organization (WHO) with at least 684 deaths [2]. 
Most zoonotic infections have occurred in the Arabian 
Peninsula, particularly in Saudi Arabia, although noso-
comial outbreaks arising from travellers coming from 
the Arabian Peninsula have been reported in Africa, 
Asia, Europe and North America. For example, between 
May and June 2015, 186 human infections in South 
Korea arose from one returning traveller [3], highlight-
ing the cause for global public health concern.
Human disease ranges from mild or asymptomatic 
infection to a fulminant viral pneumonia progressing to 
severe respiratory failure and death. Dromedary camels 
are strongly suspected to be the source of human infec-
tions [4]. It is believed that humans can get infected 
via direct contact with mucous membranes of infected 
camels [5,6] or by consuming unpasteurised camel milk 
[7]. However, the virus has not been detected in camel 
urine [8] or in raw camel meat [9]. Secondary infections 
in humans are reported, especially within nosocomial 
settings [10,11] or to a smaller extent, within house-
holds [12], suggesting that human-to-human transmis-
sion may become efficient enough to trigger outbreaks 
beyond the current epicentre in the Middle East. The 
WHO has identified MERS-CoV as one of the pathogens 
of greatest concern for global public health for which 
few or no medical countermeasures exist [13]. To date 
there are no vaccines or antivirals available for MERS-
CoV in humans [14]. Camel vaccines have given prom-
ising results with the use of a vaccinia Ankara (MVA) 
vectored vaccine [15].
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Figure 1
A. Camel densities in Africa, Middle East, and Asia with areas with prior serological evidence for MERS-CoV infection in 
camels, and B–D. sampling sites of this study, with serological and virological MERS-CoV detection rates in Burkina Faso, 
Ethiopia and Morocco, February–March 2015
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MERS-CoV only causes mild respiratory symptoms in 
camels and it is consequently not easily recognised 
and difficult to diagnose clinically. High levels of sero-
positivity and virus detection rates have been observed 
in dromedary camels in the Arabian Peninsula [16,17]. 
MERS coronaviruses detected in camels are geneti-
cally very similar or identical to those infecting humans 
[18]. MERS-CoV antibodies have also been detected 
in dromedary camel populations of many countries 
outside the Arabian Peninsula. Serological studies in 
Africa indicate high seropositivity rates and the testing 
of retrospectively collected serum samples provide evi-
dence that this virus has been infecting camels in East 
Africa since as early as 1983 [19]. More recent speci-
mens collected between 2009 and 2013 show high 
rates of detection of MERS-CoV antibodies in camels in 
Egypt, Ethiopia, Kenya, Nigeria, Sudan and Tunisia and 
also in the Canary Islands [20,21].
Surprisingly, the only indication of locally acquired pri-
mary zoonotic human infections outside the Arabian 
Peninsula is the recent detection of antibodies against 
MERS-CoV in autochthonous livestock handlers in 
Kenya between 2013 and 2014 [22]. Possible reasons 
for the absence of reports of MERS-CoV infections in 
humans in Africa may include (i) underdiagnosis in 
humans due to a possible lack of awareness, lack of 
viral diagnostic capacity and weak healthcare sys-
tems, (ii) differences in virus strains or in camel breeds 
resulting in low infectiousness towards humans, (iii) 
differences in cultural practices in interaction between 
humans and dromedary camels, or any combination of 
these. Research recommendations from workshops on 
MERS-CoV in Doha April and Cairo May 2015, organised 
by the Food and Agriculture Organisation (FAO), the 
Organisation of the United Nations for Animal Health 
(OIE) and the WHO identified the apparent absence of 
human MERS-CoV infections in Africa despite intense 
virus circulation among dromedaries as a key research 
question [23]. In order to address this question, it is 
important to understand the ecological and farming 
husbandry factors that may promote the likelihood of 
MERS-CoV infection in camels in Africa.
We report a descriptive serological and virological sur-
vey of MERS-CoV from west to east across the African 
continent, which was conducted by sampling camels 
in Burkina Faso, Ethiopia and Moroco. Sampling was 
designed so as to also assess the influence of the herd 
size, camel function (raised for milk, meat or transport) 
and lifestyle (either nomadic, sedentary or a mix of the 
two lifestyles) on likelihood of MERS-CoV infection.
Methods
Study sites and camel farming
Nomadic, sedentary, mixed lifestyles and extensive, 
semi-extensive and intensive camel breeding sys-
tems occur in African ecosystems. Extensive system/
nomadic lifestyle are characterised by the use of natural 
resources, low inputs, and herd mobility [24]. However, 
camel husbandry practices and the use of camels have 
changed in the last five decades in the following ways: 
(i) increasing camel populations in settled livestock 
farming systems, (ii) use of camels in agriculture-
related work, (iii) camel trade being more closely mar-
ket integrated and (iv) increasing importance of camels 
for the sustainability and resilience of farms which tra-
ditionally relied on cattle [25]. These changing camel 
herding practices lead to sedentary or mixed lifestyles 
with intensive or semi-intensive camel production sys-
tems (milk, meat, skin etc.) [26]. Usually, camel calves 
are suckled by their mother during the first year of life. 
Camels are considered as young and sexually imma-
ture until 2–4 years-old. Males represent 20 to 40% of 
the herd [27]. Adult males are separated from females 
and young camels in non-extensive systems because 
of their aggressiveness associated with sexual behav-
iour. In extensive systems, the male is let with non-
lactating females for reproduction only and during the 
rutting season. The contacts of adult males with young 
(less than 4 years-old) camels is not common.
Camel density increases from North to East Africa 
through the Sahelian strip with the highest densities 
recorded in the Greater Horn of Africa which harbours 
60% of the world population [9] (i.e. with 400–1,000 
individuals/100 km2 in Kenya and Somalia for instance; 
Figure 1A). Our sampling design covers Burkina Faso, 
Ethiopia and Morocco and a diversity of farming sys-
tems in different contexts (Figure 1B–D). Camel den-
sity is estimated at 0.07 individuals/km2 with 18,374 
camels in Bukina Faso, 1.99 individuals/km2 with 
2,245,581 camels in Ethiopia, and 0.44 individuals/
km2 with 197,550 camels in Morocco [27]. Camel popu-
lation densities are available at the country level only. 
However as camels are dependant on specific ecosys-
tems which are mainly deserts or tropical and subtropi-
cal grasslands, savannas and shrublands [28] (Figure 
1B–D), they are not distributed homogeneously in each 
country. Unfortunately, statistics on regional densities 
are not available.
Field work
The field work was done between February and March 
2015 in collaboration with the animal health institutes 
from Burkina Faso (Laboratoire de Biologie et Santé 
Animales - INERA-CNRST), Ethiopia (National Veterinary 
Institute) and Morocco (Institut Agronomique et 
Vétérinaire Hassan II). Cross-sectional studies were car-
ried out simultaneously in the three countries. Blood 
(for serological analyses) and nasal swabs (for virologi-
cal analyses) were collected from camels. The swabs 
were placed in virus medium transport. The blood sam-
ples were allowed to clot at room temperature and the 
serum extracted with a pipette. Swabs and sera were 
placed in cool box with ice packs if a −80 °C freezer 
was reachable in 48 h or otherwise frozen in a liquid 
nitrogen tank. On arrival at the national laboratory, all 
the samples were stored in a −80 °C freezer before their 
shipment to the international reference laboratory at 
the University of Hong Kong, for MERS-CoV serological 
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and virological analyses. Questionnaires to ascertain 
camel habitats, environment and farming practices 
were administered to the farmers by veterinarians after 
specimen collection.
Camels raised for three distinct functions (milk, meat 
or transport) were sampled. Herd size was classified 
into three categories (small with ≤ 50 camels, medium 
with 51 to 150 camels and large with 151 to 300 camels). 
Samples were collected at two types of sites, with the 
majority taken at farms (1,301 samples from 80 herds) 
and some at abattoirs (199 samples from 6 herds) in 
Ethiopia and Morocco (Table 1).
Sampled camels were classified into one of three dis-
tinct lifestyles (nomadic, sedentary or a mix of nomadic 
and sedentary). The mixed lifestyle is characterised by 
a seasonal spatial movement of less than 100 km for 
accessing new ressources while the nomadic lifestlyle 
was defined as travelling throughout the year over dis-
tances up to hundreds of kilometers.
Each region has specifities in term of farming practices 
(Figure 1B–D). For example in Morocco, camels bred for 
meat are mainly young males in small herds and are 
sent to the abattoir (i.e. Laayoun) while camels bred 
for milk are females living in large nomadic herds (i.e. 
Awsard) (see Figure 1C for the specificities by region 
covered in the study).
Biological analyses
Specimens were shipped on dry ice to the University 
of Hong Kong. Serum samples were tested for MERS-
CoV antibodies at a screening dilution of 1:20 using 
an extensively validated MERS-CoV (strain EMC) spike 
pseudoparticle neutralisation test [29]. Selected posi-
tive sera were confirmed using microneutralisation 
tests in biosafety level (BSL)3 containment [30]. Total 
Figure 2
MERS-CoV seropositivity and viral RNA detection rates estimated by modelling according to significant risk factors, 
Burkina Faso, Ethiopia and Morocco, February–March 2015
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nucleic acid was extracted from swab samples using 
the EasyMag (Biomerieux) system and tested for the 
presence of MERS-CoV RNA using the upstream of the 
envelope gene (UpE) reverse transcription-quantitative 
PCR (RT-qPCR) hydrolysis probe assay. All positive 
specimens were confirmed by a second RT-qPCR assay 
targeting the open reading frame (ORF) 1a region of the 
genome as previously described [18].
Statistical models for depicting serological and 
virological status according to geography and 
risk factors
Generalised linear mixed models (GLMM), with bino-
mial error structures, were used to depict variations in 
serological and virological status according to individ-
ual characteristics (sex and age), spatial localisation 
(country and regions) and farming practices (camel’s 
function, herd size, sampling place and lifestyle). The 
results from the abattoirs were not included in the 
risk factor modelling due to the difficulty to get reli-
able information on the farms where the animals were 
raised. However, data from the abattoir were included 
for the statistical modelling of geographical variations 
of serological and virological rates. Indeed, the pres-
ence of an abattoir in a region may strongly influence 
the likelihood of infection in that region. In the statis-
tical models, the dependent variable was binary: the 
serological and virological status of an individual was 
designated either positive or negative according to the 
result of the tests presented above. Because individu-
als were aggregated in herds, independence of sta-
tistical units was questionable. Herd random effects 
were thus included in the models. Goodness of fit was 
assessed through the Pearson overdispersion test [31]. 
Selection among models including different combina-
tions of the explanatory variables was performed using 
Akaike information criterion [31,32].
As some of explanatory variables may be collinear, 
two-by-two comparisons of explanatory variables 
were used to assess possible confounding influences. 
Cramer’s V (CrV) test was used for categorical variables 
and R2 obtained from linear models for continuous var-
iable. When the statistic is close to 1 for R2, or larger 
than 0.4 for CrV test, the two explanatory variables are 
considered as collinear and were not be used in the 
Figure 3
MERS-CoV seropositivity (antibodies) and viral RNA detection rates in camels estimated by modelling according to age, 
Burkina Faso, Ethiopia, Morocco, February–March 2015
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same statistical models. All the statistical analyses 
were performed using the software R [33].
Results
In total 1,500 camels were sampled, between February 
and March 2015, from 86 herds (Figure 1B–D and Table 
1). This included 525 camels in Burkina Faso from 43 
herds from four regions (Tinakoff, Gorom, Arbinda, 
PobéMengao); 632 camels in Ethiopia from 28 herds 
from five regions (Ayssaita-Dubti; Melkawerer; Akaki-
Addis Abeba; Metehara; Yabello) and 343 camels 
in Morocco from 15 herds from five regions (Assa-
Guelmim, Fask-Tighmert, Laayoune, Galtat Zemmour, 
Awsard).
Collinearity tests
Camel’s function and sex were strongly associated 
with each other (Table 2 and Figure 1B–D) (CrV = 0.86), 
as were region and lifestyle (CrV = 0.78); herd cat-
egory and region (CrV = 0.70); region and function 
(CrV = 0.61); herd category and country (CrV = 0.50); 
function and lifestyle (CrV = 0.41). The strongest asso-
ciation was between region and type of specimens (i.e. 
farm or abattoir) with a Cramer’s V equal to 1. Region 
and age were also slightly collinear with a R2 of 0.20.
Modelling spatial variations
At the country scale, seropositivity and virus detection 
rates varied significantly across regions with p-val-
ues < 0.005 for the regional effect (i.e. seropositivity 
and virus detection rates) (Table 3 and Figures 1 B–D).
In different regions of Burkina Faso, seropositivity 
rates ranged from 73.2% (95% confidence interval 
(CI): 48.6–88.8) to 84.6% (95% CI: 77.2–89.9) and 
virus detection from 0% (95% CI: 0–0) to 12.2% (95% 
CI: 7–20.4) (Figure 1B). In Ethiopia seropositivity rates 
ranged from 85.1% (95% CI: 71.8–92.7) to 99.4% (95% 
CI: 95.4–99.9) and the viral RNA detection rates from 
0% (95% CI: 0–0) to 15.7% (95% CI: 8.2–28.0) (Figure 
1D). In Morocco, seropositivity rates ranged from 
48.3% (95% CI: 18.3–79.5) to 100% (95% CI: 100–100) 
and viral RNA detection rates from 0% (95% CI: 0–0) to 
7.6% (95% CI: 1.9–26.1) (Figure 1C).
Taking the countries globally (irrespective of regional 
variation), seropositivity and viral RNA detection rates 
were higher in Ethiopia, as compared with Burkina 
Faso and Morocco.
Modelling risk factors
In the modelling of variations of seropositivity rates 
(Figure 2A and Table 3), the retained explanatory varia-
bles were herd size category (p-value = 0.061), camel’s 
function (p-value = 0.01) and lifestyle (p-value < 0.005).
Higher seropositivity rates were observed (i) in large/
medium herds as compared with small herds; (ii) 
in camels bred for meat or milk as compared with 
camels bred for transport, and (iii) in nomadic or 
sedentary herds than in herds with a mix of these life-
styles. Seropositivity rates also increased with age 
(p-value = 0.032; Figure 3) and were higher in females 
than in males.
Table 1
Location, numbera and characteristics of camels sampled for a cross-sectional serological and virological surey on MERS-
CoV, Burkina Faso, Ethiopia and Morocco February–March 2015 (n=1,500 camels)
Country Region Tot Inds.
Inds./
herd
Sex Function Herd sizeb Lifestyle Type
Female Male Meat Milk Transport Large Medium Small Mixed Nomadic Sedentary Abattoir Farm
Burkina 
Faso 
Gorom 127 12 66 61 52 74 1 0 0 127 0 16 111 0 127
Tinakoff 289 10 172 117 73 171 45 0 0 289 0 0 289 0 289
Arbinda 47 24 0 47 0 0 47 0 0 47 0 0 47 0 47
PobéMengao 62 31 7 55 0 7 55 0 0 62 0 0 62 0 62
Ethiopia 
Akakic 100 25 60 40 100 0 0 59 0 41 0 0 100 100 0
Ayssaita-Dubti 99 20 52 47 46 53 0 33 56 10 36 56 7 0 99
Melkawerer 199 22 111 88 88 111 0 45 0 154 0 199 0 0 199
Metehara 140 23 74 66 66 74 0 61 65 14 0 0 140 0 140
Yabello 94 24 52 42 40 54 0 33 61 0 52 33 9 0 94
Morocco 
Assa-Guelmim 24 12 20 4 0 4 0 0 0 24 0 0 24 0 24
Awsard 66 66 62 4 5 60 1 66 0 0 0 66 0 0 66
Fask-Tighmert 154 15 109 45 35 95 24 59 95 0 71 0 83 0 154
Galtat 
Zemmourc 16 16 0 16 16 0 0 0 0 16 0 0 0 16 0
Laayounec 83 83 0 83 83 0 0 0 0 83 0 0 30 83 0
Inds: individuals; MERS-CoV: Middle East respiratory syndrome coronavirus.
a Number of camels sampled according to variables tested in the modelling of spatial variations and risk factors for estimating the propability 
of detecting MERS-CoV antibodies and RNA. 
b A small herd comprised ≤ 50 camels, a medium herd between 51 and 150 camels and a large herd between 151 and 300 camels.
c Sampling took place at an abattoir.
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In the modelling of virus RNA detection rate (Figure 2B 
and Table 3), camel’s function had a significant effect 
(p-value = 0.01) with higher viral RNA detection rates 
observed in camels bred for milk or for meat as com-
pared with transport. Probability of detecting virus RNA 
also decreased with increasing age (p-value = 0.06; 
Figure 3) and was higher in females than in males 
(according to collinearity index as the variables func-
tion and sex strongly associated).
Discussion
Our results support the contention that the MERS-CoV 
is actively circulating in camel populations in Burkina 
Faso, Ethiopia, Morocco and likely across all North, 
West and East Africa. The finding of high levels of sero-
positivity rates, which is an indication of infection at 
some point in the animals’ life time, was not surpris-
ing, and was in keeping with data from previous stud-
ies in Ethiopia and in other parts of Africa [19,20,34]. 
This study, however, presents the first evidence of 
MERS-CoV activity in Burkina Faso and in Morocco 
(Figure 1A and previous mapping of MERS serological 
studies). There are few reports of virus detection in 
camels in Africa. Here, MERS-CoV RNA was detected at 
a relatively high rate of up to 15.7% (95% CI: 8.2–28.0) 
in Ethiopia, followed by Burkina Faso with up to 12.2% 
(95% CI: 7–20.4) and Morocco up to 7.6% (95% CI: 
1.9–26.1).
There is an apparent gradient of virus RNA positiv-
ity adjusted for age (Table 3) from west to east which 
could be explained by a gradient in camel density 
(Figure 1A), in addition to other drivers such as climate, 
migratory roads and national and international camel 
exchanges. Since Ethiopia is a main exporter to the 
Arabian Peninsula through two main ports in Djibouti 
and Somalia [35], the virus transmission dynamics in 
this region is of particular interest.
We observed an increase in seropositivity rate with 
age which confirms the trend observed in Ethiopia in 
a previous study [20]. We found a higher virus RNA 
detection rate in young animals compared with older 
animals which could be related to a lack of prior immu-
nity as published in previous studies in Saudi Arabia 
[36]. Young animals were naïve and more susceptible 
to virus infection (Figure 3) [37].
The role of camel density in shaping the large spatial 
scale (i.e. national) variation pattern in seropositivity 
and virus RNA detection rates is supported by the iden-
tification, at fine scale (i.e. herd), of a herd size effect 
on serological prevalence. Higher seropositivity rate 
was found in large or medium size herds as compared 
with small herds, suggesting that the transmission of 
the virus is density dependent. More studies are now 
necessary to better describe the virus transmission 
dynamics within herds and between herds, with mech-
anistic models accounting for a disease transmitted 
through close contact and the possibility of reinfec-
tions [38]. Such a model would allow to determine the 
minimum size of a camel herd required for the MERS-
CoV to persist in that herd without ‘fadeouts’: i.e. criti-
cal community size [39].
Another point highlighted by our study as a risk factor 
is the function of camels which is also related to sex. 
Camels raised for milking (which are females) show 
the highest serological prevalence followed by camels 
raised for their meat (which are mostly males) and lastly, 
camels used for transport activities (which are also 
mostly males), which have the lowest seroprevalence 
Table 2
Colinearity index among variables explaining MERS-CoV seropositivity and viral RNA detection rates
Colinearity index Age Sex Functiona Region Lifestyleb Typec Herd categoryd Country
Age 1.00
Sex 0.03 1.00
Functiona 0.04 0.86 1.00
Region 0.20 0.38 0.61 1.00
Lifestyleb 0.01 0.12 0.17 0.78 1.00
Typec 0.01 0.05 0.41 1.00 0.25 1.00
Herd categoryd 0.03 0.22 0.18 0.70 0.40 0.19 1.00
Country 0.13 0.14 0.31 1.00 0.41 0.25 0.50 1.00
Two-by-two comparisons of explanatory variables were used to assess possible confounding influences. Cramer’s V test was used for 
categorical variables and R2 obtained from linear models for continuous variables. When the statistic is close to 1 for R² or larger than 0.4 for 
CrV test, the two explanatory variables are considered as collinear and cannot be used in the same statistical models. When the statistic is 
larger than 0.4 for the CrV test the result is in bold.
a The function refers to whether the camel was bred for milk, meat or transport.
b The lifestyle refers to whether the camel was sendentary, nomadic or had a mix of sedentary and nomadic lifestyles.
c The type refers to whether samples were taken, such as a farm or a slaughterhouse.
d The herd category refers to the herd size (small with ≤ 50 camels, medium with 51 to 150 camels and large with 151 to 300 camels).
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(Table 3 and model selection). The higher seropositiv-
ity rate in females bred for milking could be related to 
the high viral RNA detection rates in younger animals, 
e.g. calves [37]. A plausible hypothesis could indeed 
be that young camels who lack antibodies have a high 
probability of being infected and in turn expose the 
mothers to infection or reinfection. The lower seroposi-
tivity rate in camels bred for their meat or for transport 
activities, which are mostly males, could also be linked 
with the fact that males are often separated from the 
herd (the two sexes are only mixed during the repro-
duction activities) and have thus less contacts with 
other camels (i.e. females and calves).
Surprisingly, there was no observed difference between 
nomadic and sedentary herds in the seropositivity rate 
or virus RNA positive rate. Two hypotheses may explain 
this pattern. Firstly, the sedentary lifestyle is found in 
animal production systems where animals live at high 
density in ‘commercial’ farms. In such situations the 
virus may be introduced more easily to the herd with 
animals being bought from other sources and the virus 
once introduced will amplify to infect most of the sus-
ceptible animals, since they are in close contact with 
each other. The virus appears to have a density depend-
ent transmission pattern. In contrast to this, nomads 
are long-distance travellers who connect different 
regions. Consequently they have multiple opportuni-
ties to come into contact with other camel populations 
during their travels, or through indirect contacts with 
water points and thus increasing the probability of 
encountering animals shedding MERS-CoV. In support 
Table 3
Multivariate modelling used to depict variations in serological and virological status according to individual characteristics 
(sex and age), spatial localisation (country and regions) and farming practices (camel’s function, herd category, and lifestyle) 
using data from Morocco, Burkina Faso and Ethiopia, February–March 2015
GLOBAL MODEL Multivariate models herd as random effect (1|herd)
VARIABLES AIC Variables P value 
SEROLOGY 
Spatial variations 
Age + country + sex + (1|herd) 1,047.8 NA NA
Age + region + sex + (1|herd) 1,029.9
Age 0.001
Region  < 0.005
Sex 0.068
Farming risk factors 
Age + sex + lifestylea + herd categoryb + (1|herd) 960.9 NA NA
Age + sex + typec + lifestylea + herd categoryb + (1|herd) 960.4 NA NA
Age + functiond + lifestylea + herd categoryb + (1|herd) 961.4
Age 0.032
Functiond 0.016
Lifestylea  < 0.005
Herd categoryb 0.061
VIRUS DETECTION RATE 
Spatial variations 
Age + country + sex + (1|herd) 640.5 NA NA
Age + region + sex + (1|herd) 619.7 NA NA
Age + region + (1|herd) 618.8
Age 0.369
Region  < 0.005
Farming risk factors 
Age + functiond + lifestylea + herd categoryb + (1|herd) 651.6 NA NA
Age + functiond + lifestylea + (1|herd) 647.8 NA NA
Age + sex + (1|herd) 651.7 NA NA
Age + functiond + (1|herd) 646.1
Age 0.067
Functiond 0.015
AIC: Akaike information criterion.
AIC Selection and p values. Each model depicts the variation of serological and virological status (response variable: positive/negative 
results) according to explanatory variables (age, country, region, sex, lifestyle, herd category, camel function). Herd random effects are 
included in the models (1 |herd). Selection among models including different combinations of these explanatory variables was performed 
using AIC where a difference of 2 is required for selecting a model which combined variables influencing significantly the response variable.
a The lifestyle refers to whether the camel was sendentary, nomadic or both.
b Herd category refers to the size of the herd (small with ≤ 50 camels, medium with 51 to 150 camels and large with 151 to 300 camels).
c The type refers to whether samples were taken such as a farm or a slaughterhouse.
d The function refers to whether the camel was bred for milk, meat or transport.
9www.eurosurveillance.org
to these interpretations, the lowest seroprevalence 
was found for the mixed lifestyle which is associated 
with medium herd sizes and relatively small range 
movements.
Our survey was limited to a narrow period in time, 
February–March 2015, and does not provide insights 
into seasonal variation in epidemiological dynamics. 
However, the synchronicity of the study across the dif-
ferent study sites is important because virus shedding 
may be related to seasonal and breeding cycles across 
these diverse geographical regions. By keeping this 
variable within relatively narrow bounds, we are able to 
meaningfully analyse the other parameters that impact 
on virus transmission dynamics within dromedary pop-
ulations. Further studies should follow camel popula-
tions through the year to define seasonal variation in 
virus activity.
The results of our study are coherent with risk factors 
highlighted by Alraddadi and colleagues for human ill-
ness in Saudi Arabia [40]. They show, using a case–
control design for exploring environmental exposures 
among primary case-patients from March to November 
2014, that direct exposure to dromedary camels and 
particularly milking camels was significantly associ-
ated to MERS-CoV illness. These results consolidate 
the risk factors identified in our study on the camel 
females and milking activities [40]. Our results also 
give rise to a number of research questions to be fol-
lowed up in future studies on MERS-CoV transmission 
dynamics in camel herds. In particular, the role played 
by young camels and the relationship with the mother 
need to be investigated more thoroughly.
Longitudinal investigations should also be undertaken 
in naturally-infected camels in different production 
systems and different age groups. Such investigations 
could provide valuable information on virus shedding 
in excretions (nasal, faecal, milk and urine) and on 
whether the virus is present in meat. It could also give 
insights into the dynamics of immunity in camels and 
reinfection mechanisms. Joint research on risk factors 
for transmission of MERS-CoV between camels, from 
camels to humans and from humans to camels should 
also be encouraged.
Genetic and phenotypic characterisation of MERS-CoV 
from Burkina Faso, Ethiopia and Morocco is required to 
understand how MERS-CoV in camels evolves within 
the continent, particularly with regard to capacity for 
inter-species transmission to humans.
Our study is one of the few studies that have so far 
addressed the influence of dromedary lifestyle on 
MERS-CoV infection as assessed by rate of seroposi-
tivity. While the study by Deem et al. (2015) in Kenya 
did not identify the factors associated with variation 
of seropositivity among farms [41], our study, which 
included different countries with a larger geographi-
cal range and included a larger number of farms with 
defined herd size, herd lifestyles and camel functions 
allowed us to explore associations of these factors 
with seropositivity. Such data contribute to under-
standing factors contributing to MERS-CoV infection 
in camels, which in turn might also have an effect on 
zoonotic infection. While we carried out our study in 
different parts of Africa, due to the fact that we have 
encompassed diverse geographical and ecological 
variables, our study findings may well be relevant in 
regions such as Saudi Arabia where zoonotic MERS 
remains a recurrent threat. Furthermore, it is not clear 
that transmission of MERS-CoV to humans is absent in 
Africa. A recent study has reported evidence of humans 
with MERS-CoV seropositivity in Kenya [22]. Further 
studies are needed to assess whether or not zoonotic 
MERS-CoV transmission occurs in Africa and our epide-
miological data provide identification of situations of 
highest risk. Better understanding of the risk factors 
and virus transmission dynamics of MERS-CoV within 
camels is important in responding to the global health 
threat posed by MERS-CoV.
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